Has Leronda Decamp received payments from drug or device companies?

Yes. Drug and device makers reported $7,259 in general payments to Leronda Decamp across 206 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Leronda Decamp did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Leronda Decamp come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Leronda Decamp

Psychiatric/Mental Health · Brooklyn, NYNPI 1689197212

Payments from drug & device makers

$7,259in general payments, 2019–2025

Across 206 payments — averaging $35.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Otsuka America Pharmaceutical, Inc.$3K
Neurocrine Biosciences, Inc.$1K
Johnson & Johnson$807
Lundbeck LLC$713
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$413
AbbVie$349
plus $1K from 9 others

What the payments were for

Food & beverage$7,259100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Otsuka America Pharmaceutical, Inc.	82	$2,582
Neurocrine Biosciences, Inc.	25	$1,090
Johnson & Johnson	12	$807
Lundbeck LLC	30	$713
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	11	$413
AbbVie	7	$349
E.r. Squibb & Sons, L.L.C.	10	$315
Alkermes, Inc.	4	$240
Axsome Therapeutics, Inc.	7	$198
Teva Pharmaceuticals USA, Inc.	8	$155
Viiv Healthcare Company	1	$125
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$125
Corium, LLC	4	$73
Vanda Pharmaceuticals Inc.	3	$45
AVEO Pharmaceuticals, Inc.	1	$28

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,259 in reported general payments places this provider in the 95th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Abilify MaintenaAripiprazole	12	$32,062
Invega SustennaPaliperidone Palmitate	13	$30,223
Risperdal ConstaRisperidone Microspheres	11	$25,307
RexultiBrexpiprazole	17	$25,083
VraylarCariprazine Hcl	14	$19,491
Clozapine	13	$2,801
Divalproex Sodium ErDivalproex Sodium	66	$1,641
Hydroxyzine Hcl	92	$1,624
Fluphenazine Hcl	14	$1,613
Paliperidone ErPaliperidone	14	$1,433
Haloperidol Decanoate	50	$1,263
Varenicline Tartrate	12	$1,243
Trazodone Hcl	132	$1,189
Quetiapine Fumarate	146	$1,143
Aripiprazole	76	$970

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti	$2,582	$57,14529 claims
Johnson & JohnsonInvega Sustenna, Risperdal Consta	$807	$55,53024 claims
AbbVieVraylar	$349	$19,49114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in Brooklyn

Leunz CadelyBrooklyn$13K
Ellen KudrowBrooklyn$12K
Rosemary FordjourBrooklyn$12K
Tiffany LawsonBrooklyn$11K
Glenn HannDansville$1.3M
Tammy RussoNiskayuna$568K
Carrie EdickSchenectady$484K
Eric SpronzCentereach$448K
Terry Jo Brooks-DevlinTonawanda$176K
Kevin SiewersStaten Island$155K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →